Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections-lymphopenia syndrome has been reported in the published literature.
Estimated prevalence: <1 in 1,000,000 (VERY_RARE).
No clinical trials have been registered for immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections-lymphopenia syndrome.
204 publications have been identified in PubMed for immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections-lymphopenia syndrome. Kisho has analyzed 99 by research type. Research spans Review / Meta-Analysis (60%), Basic Science / Preclinical (24%), and Epidemiology / Natural History (7%).
Research Type | Count | % of Total |
|---|---|---|
Research summaries | 59 |
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 11:35 PM UTC
European rare disease database
Genetic and Rare Diseases Info Center
60%
Laboratory research | 24 | 24% |
Disease patterns and progression | 7 | 7% |
Clinical study results | 4 | 4% |
Other research | 2 | 2% |
Testing and diagnosis research | 1 | 1% |
Patient case studies | 1 | 1% |
New treatment approaches | 1 | 1% |
Deraison C (2026). [PMID: 41116050](https://pubmed.ncbi.nlm.nih.gov/41116050/). *Nat Rev Gastroenterol Hepatol*. [Review / Meta-Analysis]
Srivastava H (2026). [PMID: 41790596](https://pubmed.ncbi.nlm.nih.gov/41790596/). *Expert Rev Clin Immunol*. [Review / Meta-Analysis]
Stoneman S (2026). [PMID: 41587026](https://pubmed.ncbi.nlm.nih.gov/41587026/). *JAMA*. [Review / Meta-Analysis]
Ding Y (2025). [PMID: 39541897](https://pubmed.ncbi.nlm.nih.gov/39541897/). *Comput Biol Med*. [Basic Science / Preclinical]
Roth B (2025). [PMID: 40696747](https://pubmed.ncbi.nlm.nih.gov/40696747/). *Scand J Gastroenterol*. [Epidemiology / Natural History]
Ullah H (2025). [PMID: 40078367](https://pubmed.ncbi.nlm.nih.gov/40078367/). *Front Cell Dev Biol*. [Review / Meta-Analysis]
Virone M (2025). [PMID: 40874434](https://pubmed.ncbi.nlm.nih.gov/40874434/). *Dermatol Reports*. [Review / Meta-Analysis]
Li Y (2025). [PMID: 40545809](https://pubmed.ncbi.nlm.nih.gov/40545809/). *Med Princ Pract*. [Review / Meta-Analysis]
Doenyas C (2025). [PMID: 39870727](https://pubmed.ncbi.nlm.nih.gov/39870727/). *Sci Rep*. [Other]
Momoh M (2025). [PMID: 40051209](https://pubmed.ncbi.nlm.nih.gov/40051209/). *Physiol Rep*. [Basic Science / Preclinical]